Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection (Q73210245)
Jump to navigation
Jump to search
scientific article published on 01 October 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection |
scientific article published on 01 October 1999 |
Statements
Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection (English)
A I Veldkamp
R P van Heeswijk
P L Meenhorst
J W Mulder
J M Lange